Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Titel:
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
Auteur:
Miguel, Jesus San Weisel, Katja Moreau, Philippe Lacy, Martha Song, Kevin Delforge, Michel Karlin, Lionel Goldschmidt, Hartmut Banos, Anne Oriol, Albert Alegre, Adrian Chen, Christine Cavo, Michele Garderet, Laurent Ivanova, Valentina Martinez-Lopez, Joaquin Belch, Andrew Palumbo, Antonio Schey, Stephen Sonneveld, Pieter Yu, Xin Sternas, Lars Jacques, Christian Zaki, Mohamed Dimopoulos, Meletios